Cited by 383Bariatric Surgery and OutcomesDiabetes Treatment and ManagementRegulation of Appetite and Obesity

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control

Open access
Pournaras, Dimitri J., Glicksman, Clare, Vincent, Royce P., Kuganolipava, Shophia, Alaghband-Zadeh, Jamie, Mahon, David, Bekker, Jan H.R., Ghatei, Mohammad A. +4 more·2012·Endocrinology

Abstract

Gastric bypass leads to the remission of type 2 diabetes independently of weight loss. Our hypothesis is that changes in bile flow due to the altered anatomy may partly explain the metabolic outcomes of the operation. We prospectively studied 12 patients undergoing gastric bypass and six patients undergoing gastric banding over a 6-wk period. Plasma fibroblast growth factor (FGF)19, stimulated by bile acid absorption in the terminal ileum, and plasma bile acids were measured. In canine and rodent models, we investigated changes in the gut hormone response after altered bile flow. FGF19 and total plasma bile acids levels increased after gastric bypass compared with no change after gastric banding. In the canine model, both food and bile, on their own, stimulated satiety gut hormone responses. However, when combined, the response was doubled. In rats, drainage of endogenous bile into the terminal ileum was associated with an enhanced satiety gut hormone response, reduced food intake, and lower body weight. In conclusion, after gastric bypass, bile flow is altered, leading to increased plasma bile acids, FGF19, incretin. and satiety gut hormone concentrations. Elucidating the mechanism of action of gastric bypass surgery may lead to novel treatments for type 2 diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/en.2011-2145

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 40 · Cited by 383

Authors
Pournaras, D. J., Glicksman, C., Vincent, R. P., Kuganolipava, S., Alaghband-Zadeh, J., Mahon, D., Bekker, J. H. R., Ghatei, M. A., Bloom, S. R., Walters, J. R. F., Welbourn, R., & le Roux, C. W.
Affiliations
  • Musgrove Park Hospital (GB)
  • King's College Hospital (GB)
  • Imperial College London (GB)
  • University of Pretoria (ZA)
  • Department of Investigative Medicine (D.J.P., R.P.V., M.A.G., S.R.B., C.W.l.R.), Imperial Weight Centre, Imperial College London, London W6 8RF, United Kingdom
Venue
Endocrinology
Published
2012-06-06
Volume
153
Issue
8
Pages
3613-3619
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W1974800489
Cited by
383
References
40
Citations by year
2026: 3 · 2025: 11 · 2024: 11 · 2023: 13 · 2022: 16 · 2021: 25 · 2020: 27 · 2019: 34 · 2018: 27 · 2017: 39 · 2016: 44 · 2015: 55 · 2014: 34 · 2013: 42 · 2012: 2
FWCI
43.32
Type
journal article
Language
en
Open access
Locations
  • Endocrinology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • UpSpace Institutional Repository (University of Pretoria) (submittedVersion)
Funders
  • NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
  • National Institute for Health and Care Research (DHCS/05/05)
  • Imperial College London
  • National Institutes of Health
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
Roux-en-Y gastric bypass, bile flow, bile acids, FGF19, type 2 diabetes remission, weight loss, gastric banding, incretins, terminal ileum, dietary intake, bariatric surgery
MeSH terms
Adult, Animals, Bile, Bile Acids and Salts, Blood Glucose, C-Reactive Protein, Calorimetry, Diabetes Mellitus, Type 2, Dogs, Female, Fibroblast Growth Factors, Humans, Male, Middle Aged, Gastric Bypass, Weight Loss, Rats, Wistar, Peptide YY, Rats, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review